Clinical significance of peripheral blood CD11b(+)/CD33(+)/HLA-DR(-) myeloid cells in infants and children with infectious diseases and increased CRP

類似資料

• CD33(+) HLA-DR(–) Myeloid-Derived Suppressor Cells Are Increased in Frequency in the Peripheral Blood of Type1 Diabetes Patients with Predominance of CD14(+) Subset
  著者:: Hassan, Mirhane, 等
  出版事項: (2018)
• Frequencies of CD33+CD11b+HLA-DR–CD14–CD66b+ and CD33+CD11b+HLA-DR–CD14+CD66b– Cells in Peripheral Blood as Severity Immune Biomarkers in COVID-19
  著者:: Alberca, Ricardo Wesley, 等
  出版事項: (2020)
• Immunosuppressive role of CD11b+CD33+HLA‐DR− myeloid‐derived suppressor cells‐like blast subpopulation in acute myeloid leukemia
  著者:: Shin Young Hyun, 等
  出版事項: (2020-10-01)
• Immunosuppressive role of CD11b(+)CD33(+)HLA‐DR(−) myeloid‐derived suppressor cells‐like blast subpopulation in acute myeloid leukemia
  著者:: Hyun, Shin Young, 等
  出版事項: (2020)
• Blood CD33(+)HLA-DR(−) myeloid-derived suppressor cells are increased with age and a history of cancer
  著者:: Verschoor, Chris P., 等
  出版事項: (2013)